Sareum (SAR) Competitors GBX 26.05 +3.05 (+13.26%) As of 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock SAR vs. CHI, PHD, IGR, FEN, NMT, CGO, TSI, MYN, IDE, and EVGShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include CT UK High Income Trust (CHI), Proactis (PHD), IG Design Group (IGR), Frenkel Topping Group (FEN), Neometals (NMT), Contango (CGO), Two Shields Investments Plc (TSI.L) (TSI), Mayan Energy (MYN), IDE Group (IDE), and Evgen Pharma (EVG). These companies are all part of the "financial services" industry. Sareum vs. Its Competitors CT UK High Income Trust Proactis IG Design Group Frenkel Topping Group Neometals Contango Two Shields Investments Plc (TSI.L) Mayan Energy IDE Group Evgen Pharma CT UK High Income Trust (LON:CHI) and Sareum (LON:SAR) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends. Does the media refer more to CHI or SAR? In the previous week, Sareum's average media sentiment score of 0.30 beat CT UK High Income Trust's score of 0.00 indicating that Sareum is being referred to more favorably in the news media. Company Overall Sentiment CT UK High Income Trust Neutral Sareum Neutral Do insiders & institutionals hold more shares of CHI or SAR? 51.6% of CT UK High Income Trust shares are held by institutional investors. 23.4% of CT UK High Income Trust shares are held by insiders. Comparatively, 5.0% of Sareum shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, CHI or SAR? CT UK High Income Trust has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than CT UK High Income Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCT UK High Income Trust£13.28M6.65£11.22M£0.101,060.00SareumN/AN/A-£5.28M-£4.22-6.17 Which has more volatility and risk, CHI or SAR? CT UK High Income Trust has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, Sareum has a beta of -1.08, meaning that its share price is 208% less volatile than the S&P 500. Is CHI or SAR more profitable? CT UK High Income Trust has a net margin of 84.52% compared to Sareum's net margin of 0.00%. CT UK High Income Trust's return on equity of 10.59% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets CT UK High Income Trust84.52% 10.59% 6.32% Sareum N/A -270.25%-113.80% SummaryCT UK High Income Trust beats Sareum on 10 of the 11 factors compared between the two stocks. Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£32.54M£139.18M£5.76B£3.19BDividend Yield1.10%3.74%3.91%5.04%P/E Ratio-6.173.8830.78170.55Price / SalesN/A4,145.97456.64283,242.64Price / Cash11.3213.1925.2227.94Price / Book9.9848.879.376.02Net Income-£5.28M-£90.99M£3.26B£5.89B7 Day Performance37.47%5.56%1.88%57.80%1 Month Performance42.43%6.23%3.73%52.37%1 Year Performance-12.11%183.75%28.93%108.82% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 26.05+13.3%N/A-23.3%£32.54MN/A-6.173,211High Trading VolumeCHICT UK High Income TrustN/AGBX 105.38-2.4%N/A+16.0%£87.81M£13.28M1,053.84N/ADividend AnnouncementGap DownPHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516IGRIG Design Group3.5486 of 5 starsGBX 60.27-1.2%GBX 195+223.5%-68.3%£59.15M£655.48M2.053,092FENFrenkel Topping GroupN/AGBX 48+2.1%N/A-2.5%£58.81M£34.56M55.92307NMTNeometalsN/AN/AN/AN/A£57.39MN/A-1.87N/ACGOContangoN/AGBX 0.90+12.8%N/A-38.1%£6.51MN/A-90.002,219High Trading VolumeTSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053MYNMayan EnergyN/AN/AN/AN/A£5.28M-£3K-0.235Gap UpIDEIDE GroupN/AN/AN/AN/A£3.60M£13.64M-18.13237EVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010 Related Companies and Tools Related Companies CT UK High Income Trust Competitors Proactis Competitors IG Design Group Competitors Frenkel Topping Group Competitors Neometals Competitors Contango Competitors Two Shields Investments Plc (TSI.L) Competitors Mayan Energy Competitors IDE Group Competitors Evgen Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SAR) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access